[1]
|
Douthwaite, A.H. and Lintott, S.A.M. (1983) Gastroscopic Observation of the Effect of Aspirin and Certain Other Substances on the Stomach. Lancet, 2, 1222-1225.
|
[2]
|
Gabriel, S.E. and Bombardier, C. (1990) NSAID Induced Ulcers. An Emerging Epidemic? The Journal of Rheumatology, 17, 1-4.
|
[3]
|
Sakuma, T., Gocho, S., Ogasawara, F., et al. (2012) A Case of Small Bowel Ulcer Caused by NSAIDs and Detected after Capsule Endoscope Retention. The Tokai Journal of Experimental and Clinical Medicine, 37, 14-18.
|
[4]
|
Fromm, D. (1987) How Do Non-Steroidal Anti-Inflammatory Drugs Affect Gastric Mucosal Defense? Clinical Investigative Medicine, 10, 251-258.
|
[5]
|
Whittle, B.J.R. (1977) Mechanism Underlying Gastric Mucosal Damage Induced by Indomethacin and Bile Salts, and the Actions of Prostaglandins. British Journal of Pharmacology, 60, 455-460. http://dx.doi.org/10.1111/j.1476-5381.1977.tb07522.x
|
[6]
|
Valerie V. (2005) Drug-Induced Peptic Ulcer Disease. Journal of the Malta College of Pharmacy Practice, 10, 15-19.
|
[7]
|
Matteo, F., Luca, A., Rocchina, C., Marco, T. and Corrado, B. (2011) Pathophysiology of Gastric Ulcer Development and Healing: Molecular Mechanisms and Novel Therapeutic Options. In Tech, 114-142.
|
[8]
|
Lacy, E.R. (1987) Gastric Mucosal Defense after Super Facial Injury. Clinical Investigative Medicine, 10, 189-200.
|
[9]
|
IMS Heath (2004) National Prescription Audit plusTM.
|
[10]
|
Lanza, F.L. (1998) A Guideline for the Treatment and Prevention of NSAID-Induced Ulcers. The American Journal of Gastroenterology, 93, 2037-2046. http://dx.doi.org/10.1111/j.1572-0241.1998.00588.x
|
[11]
|
Hippisley-Cox, J., Coupland, C. and Logan, R. (2005) Risk of Adverse Gastrointestinal Outcomes in Patients Taking Cyclo-Oxygenase-2 Inhibitors or Conventional Non-Steroidal Anti-Inflammatory Drugs: Population Based Nested Case-Control Analysis. British Medical Journal, 331, 1310-1316. http://dx.doi.org/10.1136/bmj.331.7528.1310
|
[12]
|
Bombardier, C., Laine, L., Reicin, A., et al. (2000) Comparison of upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. VIGOR Study Group. The New England Journal of Medicine, 343, 1520-1528. http://dx.doi.org/10.1056/NEJM200011233432103
|
[13]
|
Peter, J.W. and Lisbel, I. (1997) Colonic Drug Delivery. Drug Development and Industrial Pharmacy, 23, 893-913.
|
[14]
|
Mayur, M.P. (2011) Cutting-Edge Technologies in Colon-Targeted Drug Delivery Systems. Drug Development and Industrial Pharmacy, 8, 1245-1258.
|
[15]
|
Huiming, L., Feng, Z., Wenmin, Y., et al. (2011) Development of Multiple-Unit Colon-Targeted Drug Delivery System by Using Alginate: In Vitro and In Vivo Evaluation. Drug Development and Industrial Pharmacy, 37, 1347-1356. http://dx.doi.org/10.3109/03639045.2011.575163
|
[16]
|
Rachmawati, H., Mudhakir, D. and Kusuma, J. (2011) Combination of Inulin-Shellac as a Unique Coating Formulation for Design of Colonic Delivery Dosage Form of Ibuprofen. International Journal of Pharmaceutical Sciences and Research, 2, 1-7.
|
[17]
|
Chiarini, A., Tartarini, A. and Fini, A. (1984) pH-Solubility Relationship and Partition Coefficients for Some Anti-Inflammatory Arylaliphatic Acids. Archiv der Pharmazie, 317, 268-273. http://dx.doi.org/10.1002/ardp.19843170314
|
[18]
|
Koyama, R., Kataoka, H., Tanaka, Y., Nakatsugi, S. and Furukawa, M. (1999) Effect of Caffeine on Ibuprofen-Induced Gastric Mucosal Damage in Rats. Journal of Pharmacy and Pharmacology, 51, 817-824. http://dx.doi.org/10.1211/0022357991773014
|
[19]
|
Lanza, F.L., Royer, G.L., Nelson, R.S., Rack, M.F., Seckman, C.E. and Schwartz, J.H. (1986) Effect of Acetaminophen on Human Gastric Mucosal Injury Caused by Ibuprofen. Gut, 27, 440-443. http://dx.doi.org/10.1136/gut.27.4.440
|
[20]
|
Balasubramanian, T., Somasundaram, M. and Felix, A.J.W. (2004) Taurine Prevents Ibuprofen-Induced Gastric Mucosal Lesions and Influences Endogenous Antioxidant Status of Stomach in Rats. The Scientific World Journal, 4, 1046-1054. http://dx.doi.org/10.1100/tsw.2004.207
|
[21]
|
Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R. and Wallace, J.L. (1989) Hapten-Induced Model of Chronic Inflammation and Ulceration in the Rat Colon. Gastroenterology, 96, 795-803.
|
[22]
|
Vowinkel, T., Kalogeris, T.J., Mori, M., Christian, F., Krieglstein, D. and Granger, N. (2004) Impact of Dextran Sulfate Sodium Load on the Severity of Inflammation in Experimental Colitis. Digestive Diseases and Sciences, 49, 556-564. http://dx.doi.org/10.1023/B:DDAS.0000026298.72088.f7
|
[23]
|
Wakefield, A.J., Dhillon, A.P., Rowles, P.M., Sawyerr, A.M., Pittilo, R.M., Lewis, A.A.M. and Pounder, R.E. (1989) Pathogenesis of Crohn’s Disease: Multifocal Gastrointestinal Infarction. The Lancet, 2, 1057-1062. http://dx.doi.org/10.1016/S0140-6736(89)91078-7
|
[24]
|
Somasundaram, S., Hayllar, H., Rafi, S., Wrigglesworth, J.M., Macpherson, A.J.S. and Bjarnason, I. (1995) The Biochemical Basis of Non-Steroidal Anti Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis. Scandinavian Journal of Gastroenterology, 30, 289-299. http://dx.doi.org/10.3109/00365529509093280
|
[25]
|
Mahmud, T., Wrigglesworth, J.M., Scott, D.L. and Bjarnason, I. (1996) Mitochondrial Function and Modification of NSAID Carboxyl Moiety. InflammoPharmacology, 4, 189-194. http://dx.doi.org/10.1007/BF02735474
|
[26]
|
Vervoort L. and Kinget R. (1996) In Vitro Degradation by Colonic Bacteria on Inulin HP Incorporated in Eudragit RS Films. International Journal of Pharmaceutics, 129, 185-190. http://dx.doi.org/10.1016/0378-5173(95)04322-5
|
[27]
|
Motavallian-Naenin, A., Andalib, S., Rabbani, M., Mahzouni, P., Afsharipour, M. and Minaiyan, M. (2012) Validation and Optimization of Experimental Colitis Induction in Rats Using 2,4,6-Trinitrobenzene Sulfonic Acid. Archive of Research in Pharmaceutical Sciences, 7, 159-169.
|
[28]
|
Krimsky, M., Yedgar, S., Aptekar, L., Schwob, O., Goshen, G., Gruzman, A., et al. (2003) Amelioration of TNBS-Induced Colon Inflammation in Rats by Phospholipase A2 Inhibitor. American Journal of Physiology, 285, G586-G592.
|
[29]
|
Love, B.L. and Miller, A.D. (2012) Extended-Release Mesalamine Granules for Ulcerative Colitis. Annals of Pharmacotherapy, 46, 1529-1536. http://dx.doi.org/10.1345/aph.1R171
|
[30]
|
Ham, M. and Moss, A.C. (2012) Mesalamine in the Treatment and Maintenance of Remission of Ulcerative Colitis. Expert Review of Clinical Pharmacology, 5, 113-123. http://dx.doi.org/10.1586/ecp.12.2
|